Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anesthesia in neuromuscular diseases.

E Breucking1, W Mortier

  • 1Institut für Anästhesie, Klinikum Barmen, Wuppertal.

Acta Anaesthesiologica Belgica
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Steroid Therapy in Duchenne Muscular Dystrophy-Positive Results versus Side Effects.

Journal of clinical neuromuscular disease·2008
Same author

[Comparison of clonidine and tramadol added to prilocaine brachial plexus block - analgesia, sensory and motor block].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2005
Same author

[Neuromuscular diseases 2: muscular dystrophies (MD)].

Der Nervenarzt·2005
Same author

[Neuromuscular diseases (NME). I. Spinal muscular atrophy, peripheral nerve diseases, congenital myasthenia gravis].

Der Nervenarzt·2005
Same author

[Anaesthesia in an adult patient with a congenitally corrected transposition of the great arteries].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2003
Same author

Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.

Neurology·2003
Same journal

Intraoperatively diagnosed tracheal tear during a parathyroidec- tomy with previously undiagnosed tracheomalacia: a case report.

Acta anaesthesiologica Belgica·2018
Same journal

Ultrasound-guided axillary brachial plexus blocks for pseudo- syndactyly surgeries in a patient with epidermolysis bullosa: a case report.

Acta anaesthesiologica Belgica·2018
Same journal

Opioid-free anesthesia: what about patient comfort? A prospective, randomized, controlled trial.

Acta anaesthesiologica Belgica·2018
Same journal

Intraoperative administered tramadol reduces the need for piritramide in the immediate postoperative period in children undergoing adenotonsillectomy: A retrospective observational study.

Acta anaesthesiologica Belgica·2018
Same journal

Preoperative frailty assessment: a review.

Acta anaesthesiologica Belgica·2018
Same journal

Remifentanil PCIA during labor and delivery: can we improve maternal monitoring?.

Acta anaesthesiologica Belgica·2018
See all related articles

Anesthesia management for neuromuscular diseases presents unique challenges, including unexpected adverse reactions and potential for malignant hyperthermia. Careful patient risk evaluation is crucial for safe anesthetic procedures.

Area of Science:

  • Anesthesiology
  • Neurology
  • Internal Medicine

Background:

  • Neuromuscular diseases pose significant anesthesia-related risks.
  • Undiagnosed conditions can lead to life-threatening anesthetic complications.
  • Patients may have a predisposition to malignant hyperthermia.

Purpose of the Study:

  • To highlight anesthesia challenges in patients with neuromuscular diseases.
  • To discuss risks such as malignant hyperthermia and rhabdomyolysis.
  • To provide recommendations for anesthetic management.

Main Methods:

  • Review of clinical presentations and anesthetic complications.
  • Analysis of patient cases with neuromuscular diseases.
  • Literature synthesis on anesthetic risks and management.

Related Experiment Videos

Main Results:

  • Anesthetic adverse reactions can reveal unknown neuromuscular diseases.
  • Succinylcholine can induce severe rhabdomyolysis and hyperkalemia.
  • Cardiomyopathy necessitates avoidance of cardiodepressant agents.
  • Respiratory failure is a major concern in advanced stages.

Conclusions:

  • Individual patient risk assessment is paramount before anesthesia.
  • Specific anesthetic agents require careful consideration in myasthenia gravis and myotonias.
  • Proactive management strategies are essential for patient safety.